FDA Drug · D-0407-2026

Brimonidine Tartrate/Timolol Maleate Ophthalmic Solution 0.2%/0.5%*, 5 mL, Rx Only, Sterile, Apotex Corp. Manufactured for: Apotex Corp., Weston, FL 33326, NDC 60505-0589-1.

Class II · Ongoing

Lack of Assurance of Sterility

Affected lots / codes — check yours against thisLots VJ8599, Exp Date 09/30/2026 & VL1668, Exp Date 01/31/2027

Recalling firm: Apotex Corp., Weston, FL
Classification: Class II (temporary or reversible harm possible)
Status: Ongoing
Quantity: 107,136 vials
Distribution: U.S. Nationwide
Recall initiated: March 5, 2026
Classified: March 27, 2026
Initiation: Voluntary: Firm initiated

Official source. This record is published by the U.S. FDA through the openFDA enforcement database. View the unmodified government record:
https://api.fda.gov/drug/enforcement.json?search=recall_number%3A%22D-0407-2026%22

Important. Recalls target specific lots and codes — compare the affected lots above against your own product. This page reproduces public FDA data for readability; EveryRecall is independent and not affiliated with the FDA.

Check this brand across all 8 databases →